Urinary Bladder Matrix (UBM) Registry
NCT07805798
This study is recruiting at 3 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this registry is to collect real-world information on patients treated with Urinary Bladder Matrix (UBM) products. The study will evaluate patient characteristics, treatment patterns, and clinical outcomes to better understand how UBM products are used in routine clinical practice and the outcomes experienced by patients over time.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Tissue Repair
- Soft Tissue Reconstruction
- Wound Management
- Pressure Ulcer (PU)
- Necrotizing Soft Tissue Infection
- Fournier's Gangrene
- Pilonidal Cyst
- Open Abdomen
- Hidradenitis Suppurativa (HS)
- Lower Extremity Wound
- Incisional
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 21 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Integra LifeSciences Corporation
- Last updated on ClinicalTrials.gov
- November 20, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- HonorHealth Research Institute · Scottsdale, AZ
North Carolina · 2
- The University of North Carolina at Chapel Hill · Chapel Hill, NC
- Atrium Health · Charlotte, NC
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.